PBM ROLE IN Rx SWITCHING IS PROMOTIONAL CONCERN FOR FDA

Executive Summary

PBM ROLE IN Rx SWITCHING IS PROMOTIONAL CONCERN FOR FDA, Division of Drug Marketing, Advertising & Communication Director Lucy Rose indicated during the Drug Information Association annual meeting June 8. FDA is interested in the promotional implications of pharmacists working to switch prescriptions. One question to consider, Rose suggested, "is whether 'switch' pharmacists are acting on behalf of the company, particularly if the company owns the pharmacy," as is the case with Merck/Medco and SmithKline/DPS.